171 related articles for article (PubMed ID: 34283811)
1. TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.
de Mattos Barbosa MG; Lefferts AR; Huynh D; Liu H; Zhang Y; Fu B; Barnes J; Samaniego M; Bram RJ; Geha RS; Shikanov A; Prak ETL; Farkash EA; Platt JL; Cascalho M
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34283811
[TBL] [Abstract][Full Text] [Related]
2. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
3. TNFRSF13B in B cell responses to organ transplantation.
Cascalho M; Platt JL
Hum Immunol; 2023 Jan; 84(1):27-33. PubMed ID: 36333165
[TBL] [Abstract][Full Text] [Related]
4.
Cascalho M; Platt JL
Front Immunol; 2021; 12():634544. PubMed ID: 33679786
[TBL] [Abstract][Full Text] [Related]
5. TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA.
Platt JL; de Mattos Barbosa MG; Huynh D; Lefferts AR; Katta J; Kharas C; Freddolino P; Bassis CM; Wobus C; Geha R; Bram R; Nunez G; Kamada N; Cascalho M
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111031
[TBL] [Abstract][Full Text] [Related]
6. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
7. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene.
Sazzini M; Zuntini R; Farjadian S; Quinti I; Ricci G; Romeo G; Ferrari S; Calafell F; Luiselli D
Genes Immun; 2009 Sep; 10(6):566-78. PubMed ID: 19494827
[TBL] [Abstract][Full Text] [Related]
8. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
[TBL] [Abstract][Full Text] [Related]
9.
Shinya Y; Hiraide T; Momoi M; Goto S; Suzuki H; Katsumata Y; Kurebayashi Y; Endo J; Sano M; Fukuda K; Kosaki K; Kataoka M
J Am Heart Assoc; 2021 Feb; 10(5):e019245. PubMed ID: 33586470
[TBL] [Abstract][Full Text] [Related]
10. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.
Salzer U; Bacchelli C; Buckridge S; Pan-Hammarström Q; Jennings S; Lougaris V; Bergbreiter A; Hagena T; Birmelin J; Plebani A; Webster AD; Peter HH; Suez D; Chapel H; McLean-Tooke A; Spickett GP; Anover-Sombke S; Ochs HD; Urschel S; Belohradsky BH; Ugrinovic S; Kumararatne DS; Lawrence TC; Holm AM; Franco JL; Schulze I; Schneider P; Gertz EM; Schäffer AA; Hammarström L; Thrasher AJ; Gaspar HB; Grimbacher B
Blood; 2009 Feb; 113(9):1967-76. PubMed ID: 18981294
[TBL] [Abstract][Full Text] [Related]
11. Donor Polymorphisms in Genes Related to B-Cell Biology Associated With Antibody-Mediated Rejection After Heart Transplantation.
Marrón-Liñares GM; Núñez L; Crespo-Leiro MG; Álvarez-López E; Barge-Caballero E; Barge-Caballero G; Couto-Mallón D; Pradas-Irun C; Muñiz J; Tan C; Rodríguez ER; Vázquez-Rodríguez JM; Hermida-Prieto M
Circ J; 2018 Apr; 82(5):1351-1359. PubMed ID: 29618707
[TBL] [Abstract][Full Text] [Related]
12. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
13. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia.
Peng HL; Zhang Y; Sun NN; Yin YF; Wang YW; Cheng Z; Yan WZ; Liu SF; Xu YX; Xiao X; Zhang GS
J Thromb Haemost; 2017 Nov; 15(11):2259-2269. PubMed ID: 28834165
[TBL] [Abstract][Full Text] [Related]
14. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
Ou X; Xu S; Lam KP
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
[TBL] [Abstract][Full Text] [Related]
16. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
[TBL] [Abstract][Full Text] [Related]
18. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
19. The role of B cells and alloantibody in the host response to human organ allografts.
Vongwiwatana A; Tasanarong A; Hidalgo LG; Halloran PF
Immunol Rev; 2003 Dec; 196():197-218. PubMed ID: 14617206
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of alloreactive B cell responses by the suppression of T cell help.
Li Y; Ma L; Yin D; Shen J; Chong AS
J Immunol; 2008 May; 180(9):6077-84. PubMed ID: 18424729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
